Page 30 - Okapi Partners News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glazer Capital Announces it has Voted AGAINST the Proposed Acquisition of QEP by Diamondback Maintains its View That Merger Consideration Offered by Diamondback Continues to be Materially Inadequate Strongly Urges QEP Shareholders Vote AGAINST the Acquisition of QEP by Diamondback ISS in its Revised Recommendation Today Stated in Part That: "It is reasonably likely that if shareholders reject the transaction, QEP shares will rise above the value of the merger consideration" News provided by Share this article Share this article NEW YORK, March 11, 2021 /PRNewswire/ -- Glazer Capital, LLC ("G...

Oasis Releases Investor Presentation Recommending Changes at Stratus Properties Tuesday, March 2, 2021 9:50AM IST (4:20AM GMT)   Austin, Texas, United States:    Oasis presentation describes how overly tenured Board, poor corporate governance, and failure to execute on strategy have led to underperformance despite a booming Austin real estate market Recommends a full portfolio review and increased asset churn to narrow Stratus’ discount to NAVOasis proposes new independent, diverse directors with real estate and public board exp...

Share: DENVER, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bonanza Creek Energy, Inc. (NYSE:BCEI) (the "Company" or "Bonanza Creek") today announced that a special meeting of stockholders of the Company (the "Bonanza Creek special meeting") is scheduled to take place on March 12, 2021 at 9:00 a.m., Mountain Time. The purpose of the Bonanza Creek special meeting is to approve the issuance of Bonanza Creek common stock to stockholders and noteholders of HighPoint Resources Corporation ("HighPoint") in connection with the transaction pursuant to the Agreement and Plan of Merger, dated as of November 9, ...

Leading Proxy Advisory Firms Glass Lewis and ISS Recommend Cellular Biomedicine Group Stockholders Vote FOR Proposed Merger News provided by Share this article Share this article ROCKVILLE, Md. and SHANGHAI, Jan. 28, 2021 /PRNewswire/ -- Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("Company," "CBMG," "we" or "our"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, announced today that leading proxy advisory firms Glass, Lewis & Co. and Institutional Shareholder Services Inc. have both recommended tha...

Home / Top News / Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares Ocugen Inc. Announces Plan to Adjourn Annual Meeting of Stockholders, Modify Proposal Regarding Increase in Number of Authorized Shares Annual Meeting to be adjourned solely with respect to Item 2, and Item 2 to be modified to decrease the proposed aggregate number of shares of common stock that the Company would be authorized to issue from 500,000,000 shares to 400,000,000 shares MALVERN, Pa., Dec. 22, 2020 (GLOBE NEWSWIRE) — Ocugen, Inc...